- Home
- BROS vs CORT Comparison
BROS vs CORT Comparison
Compare BROS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BROS
- CORT
- Stock Information
- Founded
- BROS 1992
- CORT 1998
- Country
- BROS United States
- CORT United States
- Employees
- BROS N/A
- CORT N/A
- Industry
- BROS Restaurants
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BROS Consumer Discretionary
- CORT Health Care
- Exchange
- BROS Nasdaq
- CORT Nasdaq
- Market Cap
- BROS 9.1B
- CORT 7.6B
- IPO Year
- BROS 2021
- CORT N/A
- Fundamental
- Price
- BROS $59.37
- CORT $71.32
- Analyst Decision
- BROS Strong Buy
- CORT Strong Buy
- Analyst Count
- BROS 18
- CORT 4
- Target Price
- BROS $81.00
- CORT $139.00
- AVG Volume (30 Days)
- BROS 3.5M
- CORT 659.5K
- Earning Date
- BROS 11-05-2025
- CORT 10-29-2025
- Dividend Yield
- BROS N/A
- CORT N/A
- EPS Growth
- BROS 75.89
- CORT N/A
- EPS
- BROS 0.48
- CORT 1.11
- Revenue
- BROS $1,451,963,000.00
- CORT $716,080,000.00
- Revenue This Year
- BROS $27.79
- CORT $30.62
- Revenue Next Year
- BROS $24.80
- CORT $37.68
- P/E Ratio
- BROS $124.38
- CORT $63.88
- Revenue Growth
- BROS 29.80
- CORT 25.71
- 52 Week Low
- BROS $30.49
- CORT $37.82
- 52 Week High
- BROS $86.88
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BROS 36.93
- CORT 51.04
- Support Level
- BROS $63.67
- CORT $67.32
- Resistance Level
- BROS $66.77
- CORT $74.79
- Average True Range (ATR)
- BROS 2.90
- CORT 2.43
- MACD
- BROS -1.19
- CORT 0.10
- Stochastic Oscillator
- BROS 0.88
- CORT 53.55
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.